Proteomics Reveals Age as Major Modifier of Inflammatory CSF Signatures in Multiple Sclerosis | Neurology Neuroimmunology & Neuroinflammation
Background and ObjectivesMultiple sclerosis (MS) can start as relapsing or progressive. While their clinical features and treatment responses are distinct, it has remained uncertain whether their pathomechanisms differ. A notable age-related effect on MS …